EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies – BioSpace

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies – BioSpace
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies  BioSpacePublished: Jul 12, 2019. New clinical trial marks third study underway with neflamapimod in neurodegenerative disease. CAMBRIDGE, Mass., July 12, 2019 ... read more
Source: Google NewsPublished on 2019-07-12